Managed Access Programs for INC280, Capmatinib
Novartis
Novartis
Endevica Bio
AbbVie
Takeda
NanOlogy, LLC
NanOlogy, LLC
Regeneron Pharmaceuticals
Nuvation Bio Inc.
Novartis
Replimune Inc.
Janssen Research & Development, LLC
Aragon Pharmaceuticals, Inc.
Novartis
Hope Biosciences Research Foundation
Syndax Pharmaceuticals
Leap Therapeutics, Inc.
CytoDyn, Inc.
Janssen Research & Development, LLC
Daiichi Sankyo
Biogen
Jazz Pharmaceuticals
Basilea Pharmaceutica